aminoimidazole carboxamide has been researched along with imatinib mesylate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, ZK; Ding, YH; Li, YF; Shi, YY; Wei, B; Wu, JJ | 1 |
| Liang, HT; Liu, W; Tang, L; You, Y; Zhu, XJ; Zhu, XY; Zou, P | 1 |
2 other study(ies) available for aminoimidazole carboxamide and imatinib mesylate
| Article | Year |
|---|---|
[Acadesine Inhibits the Proliferation of K562 Cells and Enhances their Sensitivity to Imatinib].
Topics: Aminoimidazole Carboxamide; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Cyclin E; Humans; Imatinib Mesylate; K562 Cells; Oncogene Proteins; Ribonucleosides | 2016 |
AICAR and Decitabine Enhance the Sensitivity of K562 Cells to Imatinib by Promoting Mitochondrial Activity.
Topics: Aminoimidazole Carboxamide; Apoptosis; Cell Line, Tumor; Cell Proliferation; Decitabine; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitochondria; Protein Kinase Inhibitors; Ribonucleotides | 2020 |